Daily Tablet Shows Promise in Reversing Dementia, New Study Finds
A new study has shown that nilotinib, a drug traditionally used for blood cancer, can significantly improve cognitive and motor functions in patients with Lewy body dementia and Parkinson's disease-related dementia. The trial, involving 43 participants, demonstrated that the drug could slow or even reverse dementia symptoms, with some patients regaining abilities like speech and self-feeding. Experts suggest nilotinib may also slow Alzheimer's progression by reducing toxic protein build-up in the brain. This promising development offers a potential new treatment avenue for dementia, which affects millions and currently has no cure.